Healthcare conglomerate CVS Health Corporation (NYSE: CVS) reported mixed results for the fourth quarter of 2024, with revenues growing modestly and earnings declining sharply.
![](data:image/svg+xml;charset=utf-8,<svg height="2021px" width="1280px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
December-quarter adjusted profit plunged 44% year-over-year to $1.19 per share. On a reported basis, net income was $1.62 billion or $1.30 per share in Q4, compared to $2.05 billion or $1.58 per share in the prior-year quarter.
Revenues increased 4% year-over-year to $97.7 billion in the fourth quarter. Total same-store sales climbed 10.2% year-over-year.
“Our integrated model allows us to uniquely deliver a simpler, connected experience that saves time, saves money, and improves health,” said CVS CEO David Joyner.
